Synopsis of recent research by authors named "Wajeeha Ansari"
- Wajeeha Ansari's recent research primarily focuses on the real-world effectiveness and healthcare resource utilization of antimicrobial treatments, particularly ceftaroline fosamil, in managing complex infections and COVID-19-related health outcomes in various populations.
- Notable studies include an analysis of nirmatrelvir-ritonavir in high-risk COVID-19 patients, emphasizing its impact on hospitalization rates, as well as a multinational retrospective study evaluating ceftaroline's use in complicated skin and soft tissue infections and community-acquired pneumonia.
- Additionally, Ansari's work highlights the enduring health and economic burdens of COVID-19, assessing post-acute conditions and healthcare costs in both high-risk and low-risk patient groups, thereby contributing to the understanding of long-term COVID-19 effects in the United States.
